Top 5 Stock Picks of Eli Casdin’s Casdin Capital

3. EQRx, Inc. (NASDAQ:EQRX)

Casdin Capital’s Stake Value: $163,249,000
Percentage of Casdin Capital’s Portfolio: 7.31%
Number of Hedge Fund Holders: 38

Pharmaceutical business EQRx, Inc. (NASDAQ:EQRX) focuses mainly on developing drugs for treating immune-inflammatory illnesses and cancer in the United States. Goldman Sachs analyst Chris Shibutani initiated coverage of EQRx, Inc. (NASDAQ:EQRX) on June 13, assigning the company a ‘Buy’ rating and a price objective of $8.

At the end of Q1 2022, EQRx, Inc. (NASDAQ:EQRX) represented 7.31% of Casdin Capital’s portfolio. The hedge fund owned 39.53 million shares in EQRx, Inc. (NASDAQ:EQRX), valued at over $163.25 million.

EQRx, Inc. (NASDAQ:EQRX) has recently experienced an increase in hedge fund interest. According to Insider Monkey’s database, 38 hedge funds were bullish on EQRx, Inc. (NASDAQ:EQRX) at the end of March 2022, compared to 31 funds in the prior quarter.